A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...
A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...
Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.
Scientists have developed a breakthrough mechanism that makes the intravenous Bacillus Calmette-Guérin (BCG) tuberculosis ...
The Star Worldwide (English) on MSN4h
HENNET links vaccine stock-out to reduced budget
Health Non-Governmental Organisations Network (HENNET) has blamed low budgetary allocation for the recurring vaccine ...
Data from a late-stage study shows that treatment with PFE's PD-1 inhibitor when added to BCG improves outcomes in certain ...
A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...